HIV and Substance Use Disorders: Growing Threat of Xylazine in the Illicit Drug Supply | AIDS Education and Training Centers National Coordinating Resource Center (AETC NCRC)

Publish date:

May 15, 2024

AETC Source

These slides provide an overview on preventive and treatment approaches directed to reducing health disparities among people with co-occurring HIV and substance use disorder (SUD). Trends in xylazine exposure and the prevalence of its use are also discussed. Information on pharmacological, clinical effects, management strategies, and health risks on xylazine-related drug use are provided.